Literature DB >> 19132199

Risk of venous thromboembolism with rheumatoid arthritis.

Fadi Matta1, Ravinder Singala, Abdo Y Yaekoub, Reiad Najjar, Paul D Stein.   

Abstract

Rheumatoid arthritis is not generally considered to be a risk factor for venous thromboembolism (VTE), although abnormalities of coagulation factors have been found in patients with rheumatoid arthritis. Sparse data in a few patients suggest that patients with rheumatoid arthritis may have higher rates of VTE. The purpose of this investigation was to determine if the incidences of pulmonary embolism (PE) and deep venous thrombosis (DVT) are increased in hospitalized patients with rheumatoid arthritis. The number of patients discharged from non-Federal short-stay hospitals throughout the United States from 1979 through 2005 with a discharge code for rheumatoid arthritis was obtained from the National Hospital Discharge Survey (NHDS). Among hospitalized patients with rheumatoid arthritis who did not have joint surgery, 41,000 of 4,818,000 (0.85%) had PE compared with 3,366,000 of 891,055,000 (0.38%) among patients who did not have rheumatoid arthritis and who did not have operations or joint surgery (relative risk = 2.25). Deep venous thrombosis was diagnosed in 79,000 of 4,818,000 (1.64%) patients with rheumatoid arthritis and no joint operation, versus 7,681,000 of 891,055,000 (0.86%) who did not have rheumatoid arthritis or a joint operation (relative risk = 1.90). The relative risk of venous thromboembolism (PE and/or DVT) in these patients was 1.99. The data suggest that rheumatoid arthritis is a risk factor for VTE in hospitalized medical patients. A heightened awareness of the risks for VTE and a lower threshold for evaluation of patients for possible DVT or PE would be appropriate in caring for hospitalized patients with rheumatoid arthritis.

Entities:  

Mesh:

Year:  2009        PMID: 19132199

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  35 in total

1.  Psoriasis is associated with a greater risk of incident venous thromboembolism: the Iowa Women's Health Study.

Authors:  P L Lutsey; A E Prizment; A R Folsom
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

2.  Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Authors:  Hussain R Yusuf; W Craig Hooper; Scott D Grosse; Christopher S Parker; Sheree L Boulet; Thomas L Ortel
Journal:  Thromb Res       Date:  2014-10-22       Impact factor: 3.944

3.  Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.

Authors:  Alexis Ogdie; Neilia Kay McGill; Daniel B Shin; Junko Takeshita; Thorvardur Jon Love; Megan H Noe; Zelma C Chiesa Fuxench; Hyon K Choi; Nehal N Mehta; Joel M Gelfand
Journal:  Eur Heart J       Date:  2018-10-14       Impact factor: 29.983

4.  Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience.

Authors:  Ghaith Abu-Zeinah; Clara Oromendia; Maria T DeSancho
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

5.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

6.  Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition.

Authors:  Anetta Undas; Matthew Gissel; Beata Kwasny-Krochin; Piotr Gluszko; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  Thromb Haemost       Date:  2010-06-30       Impact factor: 5.249

Review 7.  Coagulopathies and inflammatory diseases: '…glimpse of a Snark'.

Authors:  Silvina Del Carmen; Sophie M Hapak; Sourav Ghosh; Carla V Rothlin
Journal:  Curr Opin Immunol       Date:  2018-09-27       Impact factor: 7.486

8.  Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.

Authors:  Hussain R Yusuf; W Craig Hooper; Michele G Beckman; Qing C Zhang; James Tsai; Thomas L Ortel
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

Review 9.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 10.  Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Narat Srivali; Ittikorn Spanuchart; Charat Thongprayoon; Eric L Knight
Journal:  Clin Rheumatol       Date:  2014-01-15       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.